These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11283049)

  • 1. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia.
    Broutet N; Marais A; Lamouliatte H; de Mascarel A; Samoyeau R; Salamon R; Mégraud F
    J Clin Microbiol; 2001 Apr; 39(4):1319-22. PubMed ID: 11283049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Gisbert JP; Carpio D; Marcos S; Gisbert JL; García Grávalos R; Pajares JM
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
    Louw JA; van Rensburg CJ; Hanslo D; Grundlings HD; Girdwood AH; Marks IN
    Aliment Pharmacol Ther; 1998 Jun; 12(6):545-50. PubMed ID: 9678814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.
    Catalano F; Branciforte G; Catanzaro R; Bentivegna C; Cipolla R; Nuciforo G; Brogna A
    Helicobacter; 1999 Sep; 4(3):178-84. PubMed ID: 10469192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
    Adamek RJ; Pfaffenbach B; Szymanski C
    Helicobacter; 1998 Sep; 3(3):206-11. PubMed ID: 9731993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.
    Vcev A; Stimac D; Ivandić A; Vceva A; Takac B; Pezerović D
    Aliment Pharmacol Ther; 2000 Jan; 14(1):69-72. PubMed ID: 10632647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
    De Francesco V; Zullo A; Margiotta M; Marangi S; Burattini O; Berloco P; Russo F; Barone M; Di Leo A; Minenna MF; Stoppino V; Morini S; Panella C; Francavilla A; Ierardi E
    Aliment Pharmacol Ther; 2004 Feb; 19(4):407-14. PubMed ID: 14871280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
    Goh K; Parasakthi N; Cheah P; Ranjeev C; Rosmawati M; Tan Y; Chin S
    J Gastroenterol Hepatol; 2000 Aug; 15(8):910-4. PubMed ID: 11022833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure.
    Simunić M; Ljutić D; Mise S; Pesutić-Pisac V; Tonkić M; Hozo I
    Ann Saudi Med; 2005; 25(5):425-7. PubMed ID: 16270770
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
    Sivri B; Simsek I; Hulagu S; Kadayifci A; Tozun N; Akarsu M; Uraz S; Savas MC; Koruk M; Bozbas A
    Curr Med Res Opin; 2004 Aug; 20(8):1301-7. PubMed ID: 15324533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
    Tan HJ; Rizal AM; Rosmadi MY; Goh KL
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.